Low Serum Amylase and Its Link to Metabolic Syndrome and Diabetes
Author Information
Author(s): Nakajima Kei, Nemoto Tohru, Muneyuki Toshitaka, Kakei Masafumi, Fuchigami Hiroshi, Munakata Hiromi
Primary Institution: Josai University
Hypothesis
Is low serum amylase associated with metabolic syndrome and diabetes?
Conclusion
Low serum amylase is associated with an increased risk of metabolic abnormalities, metabolic syndrome, and diabetes.
Supporting Evidence
- Lower serum amylase levels were linked to higher risks of metabolic syndrome and diabetes.
- Subjects with low serum amylase showed more metabolic abnormalities over time.
- Statistical analysis indicated significant associations between low amylase and metabolic conditions.
Takeaway
If you have low levels of a substance called amylase in your blood, it might mean you're more likely to have problems with sugar and fat in your body.
Methodology
The study examined serum amylase levels and cardiometabolic risk factors in 2,425 asymptomatic adults aged 30-80 years who underwent medical checkups.
Potential Biases
Potential bias due to exclusion of subjects with certain health conditions and reliance on self-reported data.
Limitations
The study did not measure blood insulin levels, which could provide more insight into the relationship between amylase and metabolic conditions.
Participant Demographics
Asymptomatic adults aged 30-80 years from Saitama, Japan.
Statistical Information
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website